Gopal Dhar

发表

Discovery of BMS-986260, a Potent, Selective, and Orally Bioavailable TGFβR1 Inhibitor as an Immuno-oncology Agent.

J. Fargnoli, S. Sheriff, A. Mathur, 2020, ACS medicinal chemistry letters.

CCN5/WISP-2 expression in breast adenocarcinoma is associated with less frequent progression of the disease and suppresses the invasive phenotypes of tumor cells.

S. Kambhampati, O. Tawfik, Sushanta K Banerjee, 2008, Cancer research.

Insulin-like growth factor-1 (IGF-1) induces WISP-2/CCN5 via multiple molecular cross-talks and is essential for mitogenic switch by IGF-1 axis in estrogen receptor-positive breast tumor cells.

Sushanta K Banerjee, Snigdha Banerjee, Gopal Dhar, 2007, Cancer research.

Modulation of cell-cycle regulatory signaling network by 2-methoxyestradiol in prostate cancer cells is mediated through multiple signal transduction pathways.

Sushanta K Banerjee, Snigdha Banerjee, P. V. Van Veldhuizen, 2006, Biochemistry.

2-Methoxyestradiol Inhibits Barrett's Esophageal Adenocarcinoma Growth and Differentiation through Differential Regulation of the β-Catenin–E-Cadherin Axis

Suman Kambhampati, S. Kambhampati, Sushanta K Banerjee, 2010, Molecular Cancer Therapeutics.

The MAZ transcription factor is a downstream target of the oncoprotein Cyr61/CCN1 and promotes pancreatic cancer cell invasion via CRAF–ERK signaling

S. Kambhampati, Sushanta K Banerjee, G. Maity, 2018, The Journal of Biological Chemistry.

Epidermal growth factor receptor: is a novel therapeutic target for pancreatic cancer?

Sushanta K Banerjee, Snigdha Banerjee, A. Dhar, 2005, Frontiers in bioscience : a journal and virtual library.

Molecular basis of protective effect by crocetin on survival and liver tissue damage following hemorrhagic shock

Sushanta K Banerjee, A. Dhar, Gopal Dhar, 2005, Molecular and Cellular Biochemistry.

Crocetin inhibits pancreatic cancer cell proliferation and tumor progression in a xenograft mouse model

Sushanta K Banerjee, Snigdha Banerjee, A. Dhar, 2009, Molecular Cancer Therapeutics.

Gain of oncogenic function of p53 mutants induces invasive phenotypes in human breast cancer cells by silencing CCN5/WISP-2.

M. Mayo, O. Tawfik, P. Vanveldhuizen, 2008, Cancer research.

Curcumin arrests G-quadruplex in the nuclear hyper-sensitive III1 element of c-MYC oncogene leading to apoptosis in metastatic breast cancer cells

N. Banerjee, S. Chatterjee, Ananya Roy, 2021, Journal of biomolecular structure & dynamics.

Breast cancer cells secreted platelet‐derived growth factor‐induced motility of vascular smooth muscle cells is mediated through neuropilin‐1

Gopal Dhar, Smita Mehta, K. Sengupta, 2006, Molecular carcinogenesis.

2‐Methoxyestradiol modulates β‐catenin in prostate cancer cells: A possible mediator of 2‐methoxyestradiol‐induced inhibition of cell growth

S. Kambhampati, A. Dhar, P. V. Van Veldhuizen, 2008, International journal of cancer.

Deficiency of CCN5/WISP-2-Driven Program in breast cancer Promotes Cancer Epithelial cells to mesenchymal stem cells and Breast Cancer growth

Arnab Ghosh, G. Maity, Amlan Das, 2017, Scientific Reports.

Loss of WISP-2/CCN5 signaling in human pancreatic cancer: a potential mechanism for epithelial-mesenchymal-transition.

S. Kambhampati, S. Mathur, Gopal Dhar, 2007, Cancer letters.

Tumor cell-derived PDGF-B potentiates mouse mesenchymal stem cells-pericytes transition and recruitment through an interaction with NRP-1

P. V. Van Veldhuizen, Gopal Dhar, I. Haque, 2010, Molecular Cancer.

Abstract 1727: Antitumor activity associated with dual targeting of CD38 and programmed death-1 (PD-1) pathways in preclinical models

A. Korman, R. Graziano, Natalie A. Bezman, 2018, Immunology.